INfluence of Successful Periodontal Intervention in REnal Disease (INSPIRED): study protocol for a randomised controlled pilot clinical trial.

Praveen Sharma, Paul Cockwell, Thomas Dietrich, Charles Ferro, Natalie Ives, Iain L C Chapple

Journal: Trials 2018;18(1):535

PMID: 29132440

Abstract

BACKGROUND

Patients with chronic kidney disease (CKD) exhibit increased morbidity and mortality which is associated with an increased systemic inflammatory burden. Identifying and managing comorbid diseases that contribute to this load may inform novel care pathways that could have a beneficial impact on the morbidity/mortality associated with CKD. Periodontitis, a highly prevalent, chronic inflammatory disease affecting the supporting structures of teeth, is associated with an increased systemic inflammatory and oxidative stress burden and the successful treatment of periodontitis has been shown to reduce both. This pilot study aims to gather data to inform a definitive study into the impact of successful periodontal treatment on the cardio-renal health of patients with CKD.

METHODS/DESIGN

This pilot study will employ a randomised, controlled, parallel-group design. Sixty adult patients, with CKD with a high risk of progression and with periodontitis, from the Queen Elizabeth Hospital, Birmingham, will be randomised to receive either immediate, intensive periodontal treatment (n = 30) or treatment at a delay of 12 months (n = 30). Patients will be excluded if they have reached end-stage renal disease or have received specialist periodontal treatment in the previous year. Periodontal treatment will be delivered under local anaesthetic, on an outpatient basis, over several visits by a qualified dental hygienist at the Birmingham Dental Hospital, UK. Patients in the delayed-treatment arm will continue to receive the standard community level of periodontal care for a period of 12 months followed by the intensive periodontal treatment. Randomization will occur using a centralised telephone randomisation service, following baseline assessments. The assessor of periodontal health will be blinded to the patients' treatment allocation. Patients in either arm will be followed up at 3-monthly intervals for 18 months. Aside from the pilot outcomes to inform the practicalities of a larger trial later, data on cardio-renal function, periodontal health and patient-reported outcomes will be collected at each time point.

DISCUSSION

This pilot randomised controlled trial will investigate the viability of undertaking a larger-scale study investigating the effect of treating periodontitis and maintaining periodontal health on cardio-renal outcomes in patients with CKD.

TRIAL REGISTRATION

National Institute of Health Research (NIHR) Clinical Research Network (UKCRN ID: 18458), ID: ISRCTN10227738 . Registered retrospectively to both registers on 23 April 2015.

Address: Periodontal Research Group, School of Dentistry, Institute of Clinical Sciences, Birmingham, B5 7EG, UK. [email protected].; College of Medical and Dental Sciences, University of Birmingham, and Birmingham Community Healthcare NHS Foundation Trust, Birmingham, B5 7EG, UK. [email protected].; Department of Renal Medicine, University Hospital Birmingham, Birmingham, B15 2GW, UK.; College of Medical and Dental Sciences, University of Birmingham, and Birmingham Community Healthcare NHS Foundation Trust, Birmingham, B5 7EG, UK.; Department of Oral Surgery, School of Dentistry, Institute of Clinical Sciences, Birmingham, B5 7EG, UK.; Birmingham Clinical Trials Unit (BCTU), Institute of Applied Heath Research, Birmingham, B15 2TT, UK.; Periodontal Research Group, School of Dentistry, Institute of Clinical Sciences, Birmingham, B5 7EG, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.